CDNF and Parkinson disease: Infusion of Sf9–derived recombinant human CDNF proteins into the rat brain has been shown to prevent 6-OHDA-induced dopaminergic neural degeneration in a rat model of PD or MPTP-induced PD animal models [21–24].